SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000919574-24-002417
Filing Date
2024-04-08
Accepted
2024-04-08 21:03:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 d11022702_13d-a.htm SC 13D/A 77963
  Complete submission text file 0000919574-24-002417.txt   79579
Mailing Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019
Business Address 1350 AVENUE OF THE AMERICAS SUITE 2600 NEW YORK NY 10019 212.300.5575
Casdin Capital, LLC (Filed by) CIK: 0001534261 (see all company filings)

IRS No.: 800752351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Subject) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92725 | Film No.: 24830971
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)